Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata

被引：0
|
作者：
Shapiro, Jerry [1 ]
Ko, Justin [2 ]
Egeberg, Alexander [3 ]
Somani, Najwa [4 ]
Jedynak, Jakub [4 ]
Torisu-Itakura, Hitoe [4 ]
Yu, Guanglei [4 ]
Lu, Na [5 ]
Craiglow, Brittany [6 ]
机构：
[1] New York Univ, Grossman Sch Med, New York, NY USA
[2] Stanford Med, Stanford, CA USA
[3] Copenhagen Univ Hosp Bispebjerg, Copenhagen, Denmark
[4] Eli Lilly & Co, Indianapolis, IN USA
[5] Precis Stat Consulting, Woodbury, MN USA
[6] Yale Sch Med, New Haven, CT USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
41247
引用
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [1] Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
    Senna, Maryanne M.
    Kwon, Ohsang
    Piraccini, Bianca Maria
    Sinclair, Rodney
    Ball, Susan
    Ding, Yuxin
    Chen, Yun-Fei
    Dutronc, Yves
    King, Brett
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB144 - AB144
  • [2] Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib
    King, Brett
    Ko, Justin
    Senna, Maryanne
    Tosti, Antonella
    Ohyama, Manabu
    Dutronc, Yves
    Chen, Yun-Fei
    Yu, Guanglei
    Smith, Sarah Greer
    Wu, Wen-Shuo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB29 - AB29
  • [3] Oral Baricitinib Restores Hair Loss in Alopecia Areata
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (24): : 2386 - 2386
  • [4] Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
    Senna, Maryanne M.
    McMichael, Amy J.
    Mayo, Tiffany T.
    Mackay-Wiggan, Julian
    Glashofer, Marc
    Sun, Luna
    Yu, Guanglei
    Nunes, Fabio P.
    McCollam, Jill S.
    Wu, Wen-Shuo
    King, Brett
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB85 - AB85
  • [5] Percentage of scalp-hair loss as a primary endpoint in alopecia areata trials
    Blome, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : 609 - 609
  • [6] Two Phase 3 Trials of Baricitinib for Alopecia Areata
    Alessandri-Bonetti, Mario
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (04) : 948 - 948
  • [7] Two Phase 3 Trials of Baricitinib for Alopecia Areata
    King, Brett
    Ohyama, Manabu
    Kwon, Ohsang
    Zlotogorski, Abraham
    Ko, Justin
    Mesinkovska, Natasha A.
    Hordinsky, Maria
    Dutronc, Yves
    Wu, Wen-Shuo
    McCollam, Jill
    Chiasserini, Chiara
    Yu, Guanglei
    Stanley, Sarah
    Holzwarth, Katrin
    DeLozier, Amy M.
    Sinclair, Rodney
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1687 - 1699
  • [8] Looking beyond scalp hair loss: Factors influencing dermatologists' assessment of alopecia areata severity
    Gandhi, Kavita
    Fridman, Moshe
    Ray, Markqayne
    Shy, Morgan
    Mostaghimi, Arash
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB181 - AB181
  • [9] A new self-reported measure of disease severity of scalp hair loss in alopecia areata
    Rencz, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (06) : 986 - 987
  • [10] Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss
    Gamze Serarslan
    Oğuzhan Özcan
    Ebru Okyay
    Bahar Ünlü
    Mehmet Karadağ
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1015 - 1020
12345